
ZLAB
Healthcare · Biotechnology · $3.07B market cap
$24.60-1.44 (-5.5%)Nov 13, 4:00 PM EST
Latest report
Before the open
The next earnings date isn’t on the calendar yet.
Analyst consensus
Fiscal period ending Dec 31, 2026
EPS trend, 90 days to now · +16.3% over 90 days · 30-day revisions 2 up, 1 down
Beat estimates in 2 of the last 4 reported quarters.
EPS surprise versus the estimate at the time of the report.
| Date | Session | Estimate | Actual | Surprise |
|---|---|---|---|---|
| Nov 5, 2026 | Before the open | -0.59 | -0.41 | +30.5% |
| Aug 6, 2026 | Before the open | -0.66 | -0.46 | +30.3% |
| May 12, 2026 | Time not confirmed | -0.29 | -0.46 | -58.1% |
| Feb 26, 2026 | Before the open | -0.44 | -0.46 | -4.5% |
| Nov 6, 2025 | Before the open | -0.29 | -0.33 | -13.8% |
| Aug 7, 2025 | Before the open | -0.37 | -0.37 | 0.0% |
| May 8, 2025 | Before the open | -0.55 | -0.45 | +18.2% |
| Feb 25, 2025 | Before the open | -0.63 | -0.80 | -26.3% |
| Nov 12, 2024 | Before the open | -0.78 | -0.42 | +46.2% |
| Aug 6, 2024 | After the close | -0.73 | -0.82 | -12.3% |
| May 8, 2024 | After the close | -0.92 | -0.50 | +45.7% |
| Feb 27, 2024 | After the close | -0.87 | -0.98 | -12.6% |
| Nov 7, 2023 | After the close | -1.03 |
Zai Lab Limited, a biopharmaceutical company, focuses on discovering, developing, and commercializing products that address medical conditions in the areas of oncology, immunology, neuroscience, and infectious diseases. Its commercial products include Zejula, an orally administered poly (ADP-ribose) polymerase 1/2 inhibitor for treating ovarian cancer; VYVGART, a human IgG1 antibody fragment for generalized…
| -0.71 |
| +31.1% |
| Aug 7, 2023 | After the close | -0.81 | -1.25 | -54.3% |
| May 9, 2023 | After the close | -0.97 | -0.51 | +47.4% |
| Mar 1, 2023 | After the close | -1.11 | -0.65 | +41.4% |
| Nov 9, 2022 | After the close | -1.25 | -1.68 | -34.4% |
| Aug 9, 2022 | After the close | -1.07 | -1.44 | -34.6% |
| May 10, 2022 | After the close | -1.23 | -0.86 | +30.1% |
| Mar 1, 2022 | After the close | -1.33 | -2.17 | -63.2% |
| Nov 9, 2021 | After the close | -1.27 | -1.01 | +20.5% |
| Aug 9, 2021 | After the close | -1.39 | -1.76 | -26.6% |
| May 10, 2021 | Before the open | -2.30 | -2.64 | -14.8% |
| Mar 1, 2021 | Before the open | -0.99 | -0.40 | +59.8% |
| Dec 2, 2020 | Time not confirmed | -0.40 | -0.40 | +0.5% |
| Aug 13, 2020 | Before the open | -0.99 | -0.67 | +32.3% |
| Jun 3, 2020 | Time not confirmed | -0.99 | -0.99 | +0.0% |
| Mar 19, 2020 | Before the open | -0.60 | -0.68 | -13.3% |
| Nov 27, 2019 | Time not confirmed | -0.60 | -0.60 | +0.8% |
| Sep 3, 2019 | Before the open | -0.67 | -0.43 | +35.8% |
| May 29, 2019 | Time not confirmed | -0.44 | -0.67 | -52.7% |
| Mar 7, 2019 | Before the open | -0.45 | -0.68 | -51.1% |
| Nov 28, 2018 | Time not confirmed | -0.40 | -0.33 | +17.5% |
| Sep 5, 2018 | After the close | -0.38 | -0.26 | +31.6% |
| Apr 30, 2018 | Before the open | -0.17 | -0.25 | -47.1% |